title: Development and validation of NIR-chemometric methods for chemical and pharmaceutical characterization of meloxicam tablets.
abstract: BACKGROUND
  Near-Infrared (NIR) spectroscopy is an important component of a Process Analytical Technology (PAT) toolbox and is a key technology for enabling the rapid analysis of pharmaceutical tablets.
  
  
  OBJECTIVE
  The aim of this research work was to develop and validate NIR-chemometric methods not only for the determination of active pharmaceutical ingredients content but also pharmaceutical properties (crushing strength, disintegration time) of meloxicam tablets.
  
  
  METHODS
  The development of the method for active content assay was performed on samples corresponding to 80%, 90%, 100%, 110% and 120% of meloxicam content and the development of the methods for pharmaceutical characterization was performed on samples prepared at seven different compression forces (ranging from 7 to 45 kN) using NIR transmission spectra of intact tablets and PLS as a regression method.
  
  
  RESULTS
  The results show that the developed methods have good trueness, precision and accuracy and are appropriate for direct active content assay in tablets (ranging from 12 to 18 mg/tablet) and also for predicting crushing strength and disintegration time of intact meloxicam tablets.
  
  
  CONCLUSIONS
  The comparative data show that the proposed methods are in good agreement with the reference methods currently used for the characterization of meloxicam tablets (HPLC-UV methods for the assay and European Pharmacopeia methods for determining the crushing strength and disintegration time).
  
  
  CONCLUSIONS
  The results show the possibility to predict both chemical properties (active content) and physical/pharmaceutical properties (crushing strength and disintegration time) directly, without any sample preparation, from the same NIR transmission spectrum of meloxicam tablets.
authors.affiliation: Department of Pharmaceutical Technology and Biopharmaceutics .
authors.forename: Ioan
authors.initials: I
authors.lastname: Tomuta
authors.forename: Rares
authors.initials: R
authors.lastname: Iovanov
authors.forename: Ede
authors.initials: E
authors.lastname: Bodoki
authors.forename: Loredana
authors.initials: L
authors.lastname: Vonica
mesh_terms: D002626:Chemistry, Pharmaceutical / Q000379:methods*; D002851:Chromatography, High Pressure Liquid; D016018:Least-Squares Analysis; D000077239:Meloxicam; D012044:Regression Analysis; D019265:Spectroscopy, Near-Infrared / Q000379:methods*; D013607:Tablets; D013678:Technology, Pharmaceutical / Q000379:methods*; D013843:Thiazines / Q000008:administration & dosage / Q000032:analysis / Q000737:chemistry*; D013844:Thiazoles / Q000008:administration & dosage / Q000032:analysis / Q000737:chemistry*
chemical_list: D013607:Tablets; D013843:Thiazines; D013844:Thiazoles; D000077239:Meloxicam